H.R. 4761 would require Customs and Border Protection (CBP) to develop a strategy to ensure that opioid screening devices can detect narcotics at certain purity levels. The act also would require CBP to develop a plan to ensure the longevity of those devices.
CBP is currently carrying out activities similar to those required by H.R. 4761. Thus, CBO estimates that implementing the act would not have a significant cost; any spending would be subject to the availability of appropriated funds.